Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, multicenter, double-blind, placebo-controlled, parallel-group study to
evaluate the safety and efficacy of a single dose of TNX-201 (140 mg) for the treatment of a
single qualifying Tension-Type-Headache (TTH).